BMJ22h
Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study
Department of Anaesthesia–Intensive Care Medicine, Section of Neuroanestesia and Neurocritical Care, University of Brescia, Spedali Civili, Italy Professor N Latronico, Department of ...
BMJ2d
Towards a multi-arm, multi-stage trial for disease modification in Parkinson’s: The EJS ACT-PD initiative
Background The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease initiative (EJS ACT-PD) is developing a multi-arm, multi-stage (MAMS) platform trial to accelerate identification of ...
BMJ2d
Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I
1 Expert Centre Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands 2 Department of Clinical Neurophysiology, Institute of Neurology, Radboud University Nijmegen Medical ...
BMJ2d
Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: a cohort study
Objective: There are only limited epidemiological studies evaluating the association between vertebrobasilar dolichoectasia (VBD) and outcomes. This study was designed to elucidate the outcome and ...
BMJ8d
Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
Induced pluripotent stem cells (iPSCs), which greatly circumvent the ethical issue of human embryonic stem cells (ESCs), can be induced to differentiate to dopaminergic (DA) neurons, and hence be used ...
BMJ9d
Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease
3 Alzheimer's Disease Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA 4 Udall Center for Parkinson's Research, University of Pennsylvania Perelman ...
BMJ10d
Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders
3 Working Group ‘Deep Brain Stimulation in Psychiatry: Guidance for Responsible Research and Application’. This Working Group is organised by the Europäische ...
BMJ10d
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
Background Dysfunction of the locus coeruleus-noradrenergic system occurs early in Alzheimer’s disease, contributing to cognitive and neuropsychiatric symptoms in some patients. This system offers a ...
BMJ10d
Trauma and depressive symptomatology in middle-aged persons at high risk of dementia: the PREVENT Dementia Study
Objective Depression and trauma are associated with changes in brain regions implicated in Alzheimer’s disease. The present study examined associations between childhood trauma, depression, adult ...
BMJ10d
Hypermetabolism in ALS is associated with greater functional decline and shorter survival
Correspondence to Dr Shyuan T Ngo, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia; s.ngo{at}uq.edu.au Objective To determine ...
BMJ10d
The clinical features of pathologically confirmed vascular Parkinsonism
4 Sarah Koe PSP Research Centre, UCL Institute of Neurology, London, UK 5 Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK Objective To evaluate in ...
BMJ10d
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Correspondence to Associate Professor Bruce Taylor, Menzies Research Institute Tasmania, University of Tasmania, Private Bag 23, Hobart TAS 7001, Australia; bruce.taylor{at}utas.edu.au Background ...